Sabra Health Care REIT (SBRA) Scheduled to Post Earnings on Wednesday

Sabra Health Care REIT (NASDAQ:SBRA) is set to release its earnings data after the market closes on Wednesday, August 7th. Analysts expect Sabra Health Care REIT to post earnings of $0.34 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Sabra Health Care REIT Stock Performance

SBRA stock opened at $16.35 on Wednesday. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.33 and a quick ratio of 4.33. The business has a 50-day moving average price of $15.13 and a 200 day moving average price of $14.38. The company has a market capitalization of $3.79 billion, a P/E ratio of 81.75, a PEG ratio of 2.62 and a beta of 1.24. Sabra Health Care REIT has a 1-year low of $11.73 and a 1-year high of $16.89.

Sabra Health Care REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Investors of record on Monday, May 20th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 17th. This represents a $1.20 annualized dividend and a dividend yield of 7.34%. Sabra Health Care REIT’s payout ratio is currently 600.00%.

Insider Activity

In related news, Director Catherine Cusack acquired 7,000 shares of the business’s stock in a transaction dated Wednesday, May 22nd. The shares were purchased at an average price of $14.43 per share, for a total transaction of $101,010.00. Following the completion of the acquisition, the director now directly owns 46,385 shares in the company, valued at approximately $669,335.55. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 1.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on SBRA. Scotiabank lifted their price objective on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “sector perform” rating in a report on Wednesday, May 15th. Truist Financial boosted their target price on shares of Sabra Health Care REIT from $15.00 to $16.00 and gave the stock a “buy” rating in a report on Thursday, June 27th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $16.40.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.